Phathom Pharmaceuticals Vs. Neurogene Industry Stock Comparison

Sell

20

PHAT
Phathom Pharmaceuticals

Last Price:

8.78

Seasonality Move:

-9.75%

Sell

1

NGNE
Neurogene

Last Price:

34.67

Seasonality Move:

50.43%

Sell

20

Phathom Pharmaceuticals (PHAT) is a Sell

Is Phathom Pharmaceuticals a Buy, Sell or Hold?

The current Phathom Pharmaceuticals [PHAT] share price is $8.78. The Score for PHAT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
PHAT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

1

Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

PHAT Stock Price Chart

What is Phathom Pharmaceuticals's stock price today?

The Phathom Pharmaceuticals share price today is $8.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing slight selling pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

The Neurogene share price today is $34.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

PHAT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.71	Sell
Relative Strength Index (14 RSI):	23.73	Sell
Chaikin Money Flow:	-794061	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(12.52 - 18.5)	Sell
Bollinger Bands (100):	(11.36 - 17.56)	Sell

NGNE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.55	Sell
Relative Strength Index (14 RSI):	35.74	Sell
Chaikin Money Flow:	-452975	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(41.4 - 61.5)	Sell
Bollinger Bands (100):	(34.32 - 50.52)	Sell

PHAT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	12.94	Sell
20-day SMA:	15.45	Sell
50-day SMA:	16.61	Sell
200-day SMA:	12.1	Sell
8-day EMA:	11.93	Sell
20-day EMA:	14.38	Sell
50-day EMA:	15.32	Sell
200-day EMA:	13.11	Sell

NGNE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	53.3	Sell
20-day SMA:	51.47	Sell
50-day SMA:	46.76	Sell
200-day SMA:	38.99	Sell
8-day EMA:	47.13	Sell
20-day EMA:	50.2	Sell
50-day EMA:	47.47	Sell
200-day EMA:	38.44	Sell

Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.98 per share, and an increase next year of $1.15 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Phathom Pharmaceuticals Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15
	Nov
	04	05	06	07	08	11	12	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):